London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Optimization of the constants of a MICS trifocal IOL

Poster Details

First Author: G.Lesieur FRANCE

Co Author(s):                  

Abstract Details


Analysis of the stability, refractive and visual outcomes of 300 implantations of the FineVision (MicroF, Physiol, Belgium) IOLs


Centre Ophtalmologique IRIDIS, Albi, France


This prospective non-controlled study includes outcomes after 300 consecutive implantations in 150 patients of the FineVision (MicroF, PhysIOL, Belgium) IOLs. All IOLs were introduced through MICS with the main incision at 1.8 mm at the end of the surgery. Preoperatively, the axial length, corneal power and anterior chamber depths were measured. The postoperative refraction, visual acuities at near and far were also analyzed. The surgeon factor was identified as the average position of the IOL in the eye, average position behind the iris; the median, average, and standard deviation of this SF parameter were focused on.


The IOL powers were ranging 10.5 to 29.5 D. Ninety four per cent (94,5%) of the spherical equivalents were between -0.5 D and 0.5D. Ninety two percent of eyes had a visual acuity of LogMAR 0.1 or better. The surgeon factor was 1.83±0.36 mm, ranging from 0,88 to 3,92 mm (with an outsider at 5,92 mm in an highly myopic eye). The median was 1,83 and 75% of the IOL were below 1.55 mm.


The anteroposterior position of the MICS trifocal IOL is reproducible in most of the eye configurations. Very little outsiders were found. These outsiders should be removed for the IOL optimization. FINANCIAL INTEREST: One of more of the authors... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented

Back to Poster listing